Vivos Therapeutics, Inc. · NASDAQ:VVOS
Huntsman Ronald Kirk reported 1 trade in Vivos Therapeutics, Inc. shares (Form 4)
Traded Jun 30, 2026 · Filed Sep 18, 2026
On Jun 30, 2026, Huntsman Ronald Kirk (Director, Chief Executive Officer) reported 1 trade in Vivos Therapeutics, Inc. shares at US$0.58 for US$49,828, leaving 85,910 shares. Filed Sep 18, 2026 (Form 4).
- Shares
- 85,910 shares
- Price
- US$0.58
- Value
- US$49,828
- Holding after
- 85,910 shares (held indirectly)
- Trading plan
- No
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | Preferred Stock | Other | 85,910 | US$0.58 | 85,910 | Indirect |
Source
Related
- Vivos Therapeutics, Inc.
- Huntsman Ronald Kirk
- Vivos Therapeutics, Inc. shareholders
- Schedule 13G/A · Streeterville Capital LLC · Sep 3, 2026
- Form 4 · Amman Bradford K. · Aug 26, 2026
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026
- Schedule 13G · Streeterville Capital LLC · Aug 11, 2026
- Schedule 13D · V-Co Investors 4 LLC · Jul 15, 2026